ES2162932T3 - Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que les contienen. - Google Patents

Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que les contienen.

Info

Publication number
ES2162932T3
ES2162932T3 ES95926995T ES95926995T ES2162932T3 ES 2162932 T3 ES2162932 T3 ES 2162932T3 ES 95926995 T ES95926995 T ES 95926995T ES 95926995 T ES95926995 T ES 95926995T ES 2162932 T3 ES2162932 T3 ES 2162932T3
Authority
ES
Spain
Prior art keywords
radical
derivatives
pct
methyl
streptogramine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95926995T
Other languages
English (en)
Inventor
Jean-Claude Barriere
Jean-Marc Paris
Gerard Puchault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2162932T3 publication Critical patent/ES2162932T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

DERIVADOS DE ESTREPTOGRAMINA DE FORMULA GENERAL (I) EN LA QUE EL RADICAL R{SUB,1} REPRESENTA UN RADICAL METILO O ETILO, EL RADICAL R{SUB,2} REPRESENTA UN ATOMO DE CLORO O DE BROMO, O UN RADICAL ALCENILO QUE CONTIENE 3 A 5 ATOMOS DE CARBONO, CUANDO R{SUB,} Y R{SUB,} SON METILO Y LOS SIMBOLOS R{SUB,3} Y R{SUB,4} SON UNO UN ATOMO DE HIDROGENO O UN RADICAL METILO Y EL OTRO UN RADICAL METILO. LOS DERIVADOS DE ESTREPTOGRAMINAS DE FORMULA GENERAL (I) SON PARTICULARMENTE INTERESANTES POR SU ACTIVIDAD ANTIBACTERIANA, EVENTUALMENTE EN ASOCIACION CON UN DERIVADO DE PRISTINAMICINA II.
ES95926995T 1994-08-02 1995-07-31 Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que les contienen. Expired - Lifetime ES2162932T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409563A FR2723372B1 (fr) 1994-08-02 1994-08-02 Nouveaux derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2162932T3 true ES2162932T3 (es) 2002-01-16

Family

ID=9465983

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95926995T Expired - Lifetime ES2162932T3 (es) 1994-08-02 1995-07-31 Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que les contienen.

Country Status (21)

Country Link
US (1) US5786449A (es)
EP (1) EP0772630B1 (es)
JP (2) JP3775686B2 (es)
KR (1) KR970704463A (es)
AT (1) ATE205853T1 (es)
AU (1) AU696226B2 (es)
BR (1) BR9508793A (es)
CA (1) CA2196102A1 (es)
CZ (1) CZ284383B6 (es)
DE (1) DE69522810T2 (es)
DK (1) DK0772630T3 (es)
ES (1) ES2162932T3 (es)
FR (1) FR2723372B1 (es)
GR (1) GR3036908T3 (es)
MX (1) MX9700712A (es)
NO (1) NO970240D0 (es)
NZ (1) NZ290436A (es)
PL (1) PL318435A1 (es)
PT (1) PT772630E (es)
SK (1) SK14297A3 (es)
WO (1) WO1996004299A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775288B1 (fr) * 1998-02-26 2000-03-31 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositons qui les contiennent
FR2796949B1 (fr) 1999-07-27 2001-09-21 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
WO2001007467A1 (fr) * 1999-07-27 2001-02-01 Aventis Pharma S.A. Derives de streptogramines, leur preparation et les compositions qui les contiennent
FR2796950B1 (fr) * 1999-07-27 2001-09-21 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
EP3661504A4 (en) * 2017-08-01 2021-10-13 The Regents of The University of California METHODS FOR THE PREPARATION OF STREPTOGRAMINE COMPOSITIONS AND THE USE OF THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549062B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
GR3036908T3 (en) 2002-01-31
SK14297A3 (en) 1997-08-06
ATE205853T1 (de) 2001-10-15
PT772630E (pt) 2002-02-28
NO970240L (no) 1997-01-20
MX9700712A (es) 1997-05-31
FR2723372B1 (fr) 1996-10-04
JP3775686B2 (ja) 2006-05-17
PL318435A1 (en) 1997-06-09
WO1996004299A1 (fr) 1996-02-15
NO970240D0 (no) 1997-01-20
BR9508793A (pt) 1997-12-23
EP0772630B1 (fr) 2001-09-19
DE69522810T2 (de) 2002-04-04
NZ290436A (en) 1998-07-28
DK0772630T3 (da) 2001-11-26
AU696226B2 (en) 1998-09-03
JPH10503510A (ja) 1998-03-31
AU3117395A (en) 1996-03-04
DE69522810D1 (de) 2001-10-25
US5786449A (en) 1998-07-28
CA2196102A1 (fr) 1996-02-15
JP2005290012A (ja) 2005-10-20
CZ284383B6 (cs) 1998-11-11
CZ30097A3 (en) 1997-05-14
KR970704463A (ko) 1997-09-06
JP4277015B2 (ja) 2009-06-10
EP0772630A1 (fr) 1997-05-14
FR2723372A1 (fr) 1996-02-09

Similar Documents

Publication Publication Date Title
DE69507302T2 (de) Polyalkoxylierte terpenderivate und sie enthaltende zusammensetzungen
FI961506A0 (fi) Distamysiini A -analogit antituumorisina ja antiviraalisina aineina
DK0769039T3 (da) Antifoulingsammensætninger
SE9100342D0 (sv) Novel steroid esters
NO953645D0 (no) Alkylglukosid og anvendelse derav
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
DE69510553T2 (de) Isothioharnstoff-derivate als no synthase hemmer
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
ES2162932T3 (es) Derivados de estreptogramina, su preparacion y las composiciones farmaceuticas que les contienen.
IL97277A0 (en) Beta-phenylisoserine derivative,and its preparation and application
ES2139247T3 (es) Derivados de 6-polifluoralcoxi y de 6-polifluoralquilo-2-aminobenzotiazoles.
SE9402241L (sv) Inhibitor
ES2060401T3 (es) Nuevos derivados de estroptograminas y su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 772630

Country of ref document: ES